The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

St. Jude receives $2 million pledge from InfinityQS International Inc.

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

ST. JUDE CHILDREN’S RESEARCH HOSPITAL received a pledge of $2 million over the next 10 years from InfinityQS International Inc.

St. Jude has named the Large Auditorium Gathering Space in the Marlo Thomas Center for Global Education and Collaboration in honor of InfinityQS to commemorate the company’s support.

InfinityQS received the Cardinal Stritch Donor of the Year Award, which recognizes a donor whose commitment reflects the vision and leadership of St. Jude founder Danny Thomas’ spiritual mentor, Samuel Cardinal Stritch, the Catholic archbishop of Chicago. InfinityQS has also sponsored and participated as St. Jude Heroes in three of the hospital’s annual St. Jude Memphis Marathon Weekend fundraisers.

Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

Cancer progress is not reaching everyone. Native Nations must be part of the solution.

In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.
By Rodney Haring
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account